Tag: Neonatal infection

Group B Streptococcus (GBS) is a significant cause of bloodstream infections (bacteremia) and other serious illnesses, particularly in newborns and adults with underlying medical conditions. The successful management of this condition hinges on prompt and effective antimicrobial therapy, so understanding **how to treat GBS bacteremia** is critical for a positive outcome.

Over 40% of Group B Streptococcus (GBS) infections can be caused by clindamycin-resistant strains, severely limiting treatment options for penicillin-allergic patients. This raises a critical question: Can strep B be resistant to antibiotics? The answer is a complex and evolving yes, requiring heightened clinical vigilance to ensure effective therapy.

According to the Centers for Disease Control and Prevention (CDC), approximately one in four pregnant women carry Group B Streptococcus (GBS) bacteria. While typically harmless in healthy adults, the critical question of whether **does group B strep require antibiotics** depends on a patient's specific health status and, most importantly, whether they are pregnant.